A new statewide collaboration between the Wisconsin Hospital Association (WHA) and the UW School of Medicine and Public Health aims to bring much needed help to rural communities grappling with a rise in substance use and addiction. The new program, named Wisconsin Rural Health & Substance Use Clinical Support (RHeSUS), seeks to improve access to evidence-based care for rural residents struggling with substance use disorders by enhancing capacity for delivering this care in rural primary care and hospital settings. This waiver course is appropriate for all medical providers from rural Wisconsin communities, and WHA encourages sharing this information with providers who may be interested.
The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training necessary for prescribers to obtain a waiver to engage in office‐based treatment of opioid use disorders with buprenorphine. This course addresses those requirements and covers all evidence-based practices and medications for treating patients with opioid use disorder. The American Society of Addiction Medicine Treatment of Opioid Use Disorder Course is designed for:
- Physicians, nurse practitioners, physician assistants and health care team members working with patients with opioid use disorder.
TOUD Waiver Course
- Physicians, nurse practitioners and physician assistants who wish to obtain a waiver to prescribe buprenorphine in oﬃce-based treatment of opioid use disorder.
Virtual course delivered by Dr. Randall Brown, Project ECHO at the University of Wisconsin School of Public Health, Department of Family Medicine and Community Health and colleagues.
July 19, 2022, 12:30-5 PM
For more information, contact Jill Lindwall, RHeSUS program director at Jlindwall@wha.org
or Kathleen Maher, UW outreach coordinator at Kathleen.Maher@fammed.wisc.edu.
Funding for RHeSUS was provided by the UW School of Medicine and Public Health from the Wisconsin Partnership Program.